This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Impax Laboratories, Inc.
Drug Names(s): IPX054, carbidopa-levodopa immediate- and extended-release
Description: IPX-054 is a bi-layer formulation of carbidopa/levodopa; levodopa is a precursor to dopamine and carbidopa inhibits the enzyme DDC from metabolizing levodopa before it reaches the brain.
Pink Sheet Future unclear for Impax Parkinson’s drug
Pink Sheet Licensing In Brief
Pink Sheet ‘Complete Response’ Letters
Additional information available to subscribers only: